Historic 1994 influenza vaccine cohorts define breadth of antibody and B cell responses toward future influenza A and B viruses
Science Translational Medicine · 2026
DOI: 10.1126/scitranslmed.aea8621 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Translational Medicine, 2026. Verfasst von Thi H O Nguyen und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Aus…. Hauptthemen laut MEDLINE: Influenza Vaccines, B-Lymphocytes, Antibodies, Viral, Influenza B virus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: NHMRC.
Abstract (Originalsprache)
Vaccination is the best way to combat annual influenza epidemics, yet the breadth of vaccine-induced humoral immunity toward decades of future differentially evolving influenza A (IAV) and influenza B (IBV) viruses is unclear. Using historic 1994 influenza vaccination cohorts of young and older adults, we defined antibody responses elicited by 1994 vaccination against future influenza strains spanning three decades of differentially evolving IAV and IBV strains. Quality of antibody responses and vaccine-induced and cross-reactive B cell memory responses were investigated. Vaccination increased antibody titers against all 1994 vaccine components in younger and older adults. Antibodies to future H1N1 strains were also detected across younger and older adults, including nonneutralizing hemagglutinin (HA) stem responses. Prominent boosting against earlier B/Yamagata/16/1988 and future Yamagata lineage strains was also observed, but antibody responses toward future rapidly evolving H3N2 strains were minimal. Systems serology revealed divergent antibody signatures between younger and older adults against future antigens. However, postvaccination responses were of high quality in both age groups. Cross-reactive HA-specific memory B cells induced by 1994 vaccination bound to vaccine and future H1 and IBV strains but exhibited minimal responses against H3. Group 1 cross-reactive H1/H5 stalk–specific responses also contributed to the overall H1 future response, whereas cross-reactive H3/H7 stalk–specific B cells were not detected. Our study provides insights into the breadth of vaccine-induced humoral immunity toward future influenza viruses over 30 years of influenza virus evolution, including newly emerging pandemic strains, and highlights the unmet need to optimize future vaccines strategies, especially for H3N2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia.
- WHO Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia.
- Department of Electrical and Electronic Engineering, University of Melbourne, Melbourne, Victoria 3010, Australia.
- Victorian Infectious Diseases Reference Laboratory, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia.
- Burnet Institute, Melbourne, Victoria 3004, Australia.
- Melbourne Sexual Health Centre and Department of Infectious Diseases, Alfred Health, Central Clinical School, Monash University, Melbourne, Victoria 3004, Australia.
ORCID-Profile: Thi H O Nguyen, Isabelle J H Foo, Ruth A Purcell, Hyon-Xhi Tan, Georgia Deliyannis, Wuji Zhang, Louise Carolan, Howard H Huang, Lilith F Allen, Ruth R Hagen, L Carissa Aurelia, Hayley A McQuilten, Louise C Rowntree, Lukasz Kedzierski, Samuel H Wilks, Stephen J Kent, Annette Fox, Amy W Chung, Adam K Wheatley, Katherine Kedzierska
Förderung
- NHMRC
Zitieren
APA
Nguyen, T. H. O., Foo, I. J. H., Purcell, R. A., Tan, H. X., Deliyannis, G., Zhang, W., Carolan, L., Hadiprodjo, A. J., Huang, H. H., Allen, L. F., Hagen, R. R., Aurelia, L. C., McQuilten, H. A., Rowntree, L. C., Kedzierski, L., Wilks, S. H., McKay, M. R., Tannock, G. A., Kent, S. J., …, & Kedzierska, K. (2026). Historic 1994 influenza vaccine cohorts define breadth of antibody and B cell responses toward future influenza A and B viruses. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.aea8621
Vancouver
Nguyen THO, Foo IJH, Purcell RA, Tan HX, Deliyannis G, Zhang W, et al. Historic 1994 influenza vaccine cohorts define breadth of antibody and B cell responses toward future influenza A and B viruses. Science Translational Medicine. 2026. doi:10.1126/scitranslmed.aea8621
BibTeX
@article{Nguyen2026,
author = {Nguyen, Thi H O and Foo, Isabelle J H and Purcell, Ruth A and Tan, Hyon-Xhi and Deliyannis, Georgia and Zhang, Wuji and Carolan, Louise and Hadiprodjo, A Jessica and Huang, Howard H and Allen, Lilith F and Hagen, Ruth R and Aurelia, L Carissa and McQuilten, Hayley A and Rowntree, Louise C and Kedzierski, Lukasz and Wilks, Samuel H and McKay, Matthew R and Tannock, Gregory A and Kent, Stephen J and Laurie, Karen and Fox, Annette and Rockman, Steven and Brown, Lorena E and Chung, Amy W and Wheatley, Adam K and Kedzierska, Katherine},
title = {Historic 1994 influenza vaccine cohorts define breadth of antibody and B cell responses toward future influenza A and B viruses},
journal = {Science Translational Medicine},
year = {2026},
doi = {10.1126/scitranslmed.aea8621}
}
EUVIMED